Caris Life Sciences, Inc. Common Stock Working Capital to Net Assets Ratio
Caris Life Sciences, Inc. Common Stock working capital to net assets ratio. Caris Life Sciences, Inc. Common Stock (CAI) has a Working Capital to Net Assets ratio of 146.4% as of June 2026. Working capital of $866.39 Million (current assets of $1.06 Billion minus current liabilities of $191.44 Million) is measured against net assets of $591.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check CAI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Caris Life Sciences, Inc. Common Stock (2005–2025)
Working capital to net assets ratio of Caris Life Sciences, Inc. Common Stock from 2005 to 2025. This chart shows how Caris Life Sciences, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 146.4%, reflecting working capital of $866.39 Million against net assets of $591.73 Million USD. See CAI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Caris Life Sciences, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2005–2025)
Caris Life Sciences, Inc. Common Stock working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Caris Life Sciences, Inc. Common Stock from 2005 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CAI current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 150.8% | $870.65 Million | $577.31 Million | $997.80 Million | $127.14 Million | ▲ +152.8 pp |
| 2024 | -2.0% | $50.31 Million | $-2.50 Billion | $215.73 Million | $165.42 Million | ▲ +4.9 pp |
| 2023 | -6.9% | $147.47 Million | $-2.14 Billion | $242.61 Million | $95.14 Million | ▲ +15.4 pp |
| 2022 | -22.3% | $379.14 Million | $-1.70 Billion | $516.04 Million | $136.91 Million | ▼ -7.2 pp |
| 2020 | -15.0% | $-105.59 Million | $702.24 Million | $214.66 Million | $320.25 Million | ▼ -45.6 pp |
| 2019 | 30.5% | $211.72 Million | $693.24 Million | $499.13 Million | $287.41 Million | ▲ +59.9 pp |
| 2018 | -29.3% | $-205.51 Million | $701.13 Million | $220.02 Million | $425.53 Million | ▼ -8.1 pp |
| 2017 | -21.2% | $-119.59 Million | $563.85 Million | $140.34 Million | $259.93 Million | ▼ -14.9 pp |
| 2016 | -6.3% | $-28.85 Million | $457.50 Million | $135.15 Million | $164.01 Million | ▲ +9.7 pp |
| 2015 | -16.0% | $-73.77 Million | $461.26 Million | $144.11 Million | $217.88 Million | ▲ +7.6 pp |
| 2014 | -23.6% | $-104.39 Million | $442.90 Million | $144.80 Million | $249.19 Million | ▼ -17.3 pp |
| 2013 | -6.3% | $-25.98 Million | $415.13 Million | $130.97 Million | $156.94 Million | ▼ -2.9 pp |
| 2012 | -3.4% | $-11.66 Million | $346.85 Million | $95.11 Million | $106.78 Million | ▼ -1.7 pp |
| 2011 | -1.7% | $-4.15 Million | $248.74 Million | $74.90 Million | $79.05 Million | ▲ +41.6 pp |
| 2010 | -43.3% | $-85.51 Million | $197.67 Million | $68.65 Million | $154.16 Million | ▼ -62.6 pp |
| 2009 | 19.3% | $24.93 Million | $129.10 Million | $63.38 Million | $38.45 Million | ▼ -12.1 pp |
| 2008 | 31.4% | $35.75 Million | $113.79 Million | $80.99 Million | $45.24 Million | ▲ +33.9 pp |
| 2007 | -2.4% | $-3.20 Million | $131.15 Million | $53.43 Million | $56.63 Million | ▲ +62.6 pp |
| 2006 | -65.0% | $-18.05 Million | $27.75 Million | $59.52 Million | $77.56 Million | ▼ -54.2 pp |
| 2005 | -10.8% | $-3.58 Million | $32.99 Million | $41.40 Million | $44.97 Million | — |